The market for retail pharmacy sales rose 15.8% during the second quarter, according to Newton, PA-based Scott-Levin. In its "Source Prescription Audit," the company reported that pharmaceutical companies generated a total of $20.7 billion during the quarter.
The market for retail pharmacy sales rose 15.8% during the second quarter, according to Newton, PA-based Scott-Levin. In its "Source Prescription Audit," the company reported that pharmaceutical companies generated a total of $20.7 billion during the quarter.
Driven by the success of Imitrex, Flonase, Epivir and Serevent, Glaxo Wellcome was responsible for the largest portion (6.7%) of retail pharmacy sales. Merck added the second largest share (6.5%) with Aocor, Fosamax, Cozaar and Hyzaar. Pfizer contributed the third largest sales (6.2%) with strong performances by Norvasc, Cardura, Zithromax and Zyrtec.
American Home Products and Bristol-Myers Squibb rounded out the top five in second-quarter sales with 6% and 5.7%, respectively.
Four of the top 10 corporations increased their U.S. retail pharmacy dollars by more than 20%: Eli Lilly and SmithKline Beecham raised their revenues by 21%; Bristol-Myers Squibb improved its stance by 24%; and Schering-Plough boosted its sales by 32%. PR
Fierce Females in the Life Science Space
March 29th 2024In this week’s episode, in recognition of international women’s month, Editor Miranda Schmalfuhs has compiled audio clips from interviews with female KOLs that she's been fortunate enough to speak with over this past month for content across a few of our brands.